Cited by 1,111Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolismCellular transport and secretion

Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy

Open access
Tanida, Isei, Minematsu-Ikeguchi, Naoko, Ueno, Takashi, Kominami, Eiki·2005·Autophagy

Abstract

During starvation-induced autophagy in mammals, autophagosomes form and fuse with lysosomes, leading to the degradation of the intra-autophagosomal contents by lysosomal proteases. During the formation of autophagosomes, LC3 is lipidated, and this LC3-phospholipid conjugate (LC3-II) is localized on autophagosomes and autolysosomes. While intra-autophagosomal LC3-II may be degraded by lysosomal hydrolases, recent studies have regarded LC3-II accumulation as marker of autophagy. The effect of lysosomal turnover of endogenous LC3-II in this process, however, has not been considered. We therefore investigated the lysosomal turnover of endogenous LC3-II during starvation-induced autophagy using E64d and pepstatin A, which inhibit lysosomal proteases, including cathepsins B, D and L. We found that endogenous LC3-II significantly accumulated in the presence of E64d and pepstatin A under starvation conditions, increasing about 3.5 fold in HEK293 cells and about 6.7 fold in HeLa cells compared with that in their absence, whereas the amount of LC3-II in their absence is cell-line dependent. Morphological analyses indicated that endogenous LC3-positive puncta and autolysosomes increased in HeLa cells under starvation conditions in the presence of these inhibitors. These results indicate that endogenous LC3-II is considerably degraded by lysosomal hydrolases after formation of autolysosomes, and suggest that lysosomal turnover, not a transient amount, of this protein reflects starvation-induced autophagic activity.

AI snapshot

Written from the paper’s full text.

TL;DR

The paper shows that endogenous LC3-II is rapidly degraded by lysosomal hydrolases during starvation-induced autophagy, so the cellular level of LC3-II alone does not reliably indicate autophagic activation. Measuring LC3-II in the presence versus absence of E64d and pepstatin A reveals lysosomal turnover and better estimates autophagy.

Key findings

  • Under starvation conditions, endogenous LC3-II was about 3.5-fold higher in HEK293 cells and about 6.7-fold higher in HeLa cells when treated with E64d and pepstatin A than without these inhibitors.
  • In HEK293 cells, without inhibitors LC3-II increased 2 h after starvation induction but slightly decreased at 4 h; with E64d and pepstatin A, LC3-II increased dramatically in a time-dependent manner.
  • In HeLa cells, LC3-positive puncta and autolysosomes accumulated with E64d and pepstatin A under starvation; autolysosomes per 100 µm² of cytoplasmic area were about 7.3-fold higher with inhibitors than without.
  • In A431, MDA-MB-231, and SK-N-SH cells, endogenous LC3-II was present under nutrient-rich conditions despite S6RP phosphorylation, suggesting LC3-II levels are not a simple marker for autophagic activity.

Methods

  • HeLa and HEK293 cells were cultured in DMEM with 10% FCS and starved in Krebs-Ringer medium; E64d (10 µg/ml) and pepstatin A (10 µg/ml) were used to inhibit lysosomal proteases.
  • Endogenous LC3-I and LC3-II were analyzed by immunoblotting with anti-human LC3 antibody and densitometry; Tor pathway activity was monitored using phospho- and total S6RP, S6K, and Tor antisera.
  • LC3 localization was examined by immunofluorescence with Alexa Fluor594-conjugated anti-LC3 antibody and 2D blind deconvolution; autophagosomes/autolysosomes were examined by electron microscopy.

Limitations

  • Stated: the anti-human LC3 antibody was not suitable for immunoelectron microscopy, so the relationship between LC3 and autolysosomes could not be directly confirmed by immunoelectron microscopy.
  • Stated: there is no evidence for a Cvt-like pathway in mammalian cells, which is offered as one possible explanation for LC3-II under nutrient-rich conditions.
  • Evident: the conclusions rely on pharmacological protease inhibitors and cultured cell lines; no in vivo animal validation is described in this paper. The comparison of endogenous LC3 with GFP-human LC3 is cited as unpublished results and is not shown.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4161/auto.1.2.1697

Cites

0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 2 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    In the presence of E64d and pepstatin A, LC3-positive puncta accumulate under starvation conditions in both HeLa and HEK293 cells.

    “In the presence of these inhibitors, LC3-II dramatically accumulates under starvation conditions in both HeLa and HEK293 cells, as do LC3-positive puncta and autolysosomal structures.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: E64d and pepstatin A inhibit the proteolytic activities of cathepsins B, D and L, causing autolysosomes containing cytosolic components to accumulate.
  • Findingown data

    GFP-human LC3 tended to accumulate less than endogenous LC3 in the presence of E64d and pepstatin A under starvation conditions.

    “When we compared the lysosomal degradation of endogenous LC3 with that of GFP-human LC3, we found that GFP-human LC3 tended to accumulate less than endogenous LC3 in the presence of E64d and pepstatin A under starvation conditions (Tanida I, Ueno T, Kominami E, unpublished results”
    Quote in the paperSubstantial claim
  • Findingown data

    In the presence of E64d and pepstatin A, LC3-II dramatically accumulates under starvation conditions in both HeLa and HEK293 cells.

    “In the presence of these inhibitors, LC3-II dramatically accumulates under starvation conditions in both HeLa and HEK293 cells, as do LC3-positive puncta and autolysosomal structures.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: E64d and pepstatin A inhibit the proteolytic activities of cathepsins B, D and L, causing autolysosomes containing cytosolic components to accumulate.
  • Findingown data

    In the presence of E64d and pepstatin A, autolysosomal structures accumulate under starvation conditions in both HeLa and HEK293 cells.

    “In the presence of these inhibitors, LC3-II dramatically accumulates under starvation conditions in both HeLa and HEK293 cells, as do LC3-positive puncta and autolysosomal structures.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: E64d and pepstatin A inhibit the proteolytic activities of cathepsins B, D and L, causing autolysosomes containing cytosolic components to accumulate.
  • Findingown data

    In HeLa cells, LC3-II decreases under starvation conditions in the absence of E64d and pepstatin A.

    “Furthermore, in HeLa cells, LC3-II decreases under starvation conditions in the absence of E64d and pepstatin A, while it increases under the same conditions in HEK293 cells.”
    Quote in the paperSubstantial claim
  • May combine two claims. 2
  • May combine two claims.

    Interpretationcitation

    During the impairment of autophagosome-lysosome fusion, LC3 is lipidated and LC3-II accumulates.

    “Furthermore, inhibiting the fusion of autophagosomes with lysosomes using rab7 RNAi led to the accumulation of LC3-II, indicating that during the impairment of autophagosome-lysosome fusion LC3 is lipidated and LC3-II accumulates.52”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [52]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning

    An increase in the amount of endogenous LC3-II can occur under three conditions: (1) lipidation of LC3-I to form LC3-II during autophagosome-formation, (2) inhibition of the fusion of autophagosomes with lysosomes, and (3) inhibition of lysosomal degradation.

    “However, an increase in the amount of endogenous LC3-II can occur under three conditions: (1) lipidation of LC3-I to form LC3-II during autophagosome-formation, (2) inhibition of the fusion of autophagosomes with lysosomes, and (3) inhibition of lysosomal degradation.”
    Quote in the paperSubstantial claim
2 of 2
  • The paper relies on this without support.

    E64d and pepstatin A inhibit the proteolytic activities of cathepsins B, D and L, causing autolysosomes containing cytosolic components to accumulate.

    “When E64d and pepstatin A are added to the medium, the proteolytic activities of these cathepsins are inhibited, and autolysosomes containing cytosolic components accumulate.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Figure 3B is cited as starvation-condition LC3-II evidence

    Minor

    The text cites Figure 3B for increased LC3-II under starvation, but the figure caption identifies panel B as a nutrient-rich-condition fluorescence image. The caption assigns starvation conditions to other panels.

1 of 1

Cites

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 8

  1. Ohsumi Y. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2:211-6.
  2. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001; 8:569-81.
  3. Klionsky DJ. Cell biology: Regulated self-cannibalism. Nature 2004; 431:31-2.
  4. Pfeifer U. Functional morphology of the lysosomal apparatus. In: Glaumann H, Ballard FJ, eds. Lysosomes: Their role in protein breakdown. London: Academic Press, 1987:3-59.
  5. Seglen PO. Regulation of autophagic protein degradation in isolated liver cells. In: Glaumann H, Ballard FJ, eds. Lysosomes: Their role in protein breakdown. London: Academic Press, 1987:371-414.
  6. Andersson G, Glaumann H. Current Methods for the isolation of coated vesicles, endo- cytic vesicles, the Golgi complex, lysosomes and autophagic vacuoles. In: Glaumann H, Ballard FJ, eds. Lysosomes: Their role in protein breakdown. London: Academic Press, 1987:61-113.
  7. Kirschke H, Barrett AJ. Chemistry of lysosomal proteases. In: Glaumann H, Ballard FJ, eds. Lysosomes: Their role in protein breakdown. London: Academic Press, 1987:193-238.
  8. Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004; 36:2491-502.

Cited by

Sorted by citations

Authors
Tanida, I., Minematsu-Ikeguchi, N., Ueno, T., & Kominami, E.
Affiliations
Juntendo University (JP)
Venue
Autophagy
Published
2005-07-05
Volume
1
Issue
2
Pages
84-91
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
OpenAlex
W1990138203
Cited by
1,108
References
0
Citations by year
2026: 27 · 2025: 36 · 2024: 30 · 2023: 42 · 2022: 63 · 2021: 79 · 2020: 67 · 2019: 87 · 2018: 61 · 2017: 70 · 2016: 62 · 2015: 58 · 2014: 54 · 2013: 72 · 2012: 55
FWCI
20.29
Type
journal article
Language
en
Open access
Locations
  • Autophagy (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Private School Promotion Foundation
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
LC3-II, starvation-induced autophagy, autolysosomes, lysosomal proteases, cathepsins, E64d, pepstatin A, autophagosome formation, autophagy markers, LC3 lipidation
MeSH terms
Autophagy, Biological Transport, Active, Cell Line, Humans, Hydrolases, Leucine, Lysosomes, Microtubule-Associated Proteins, Pepstatins, Phagosomes, Biomarkers, Microscopy, Electron, Transmission

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-15.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-15.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review